D. E. Shaw & Co., Inc. - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 63 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 7.68 and the average weighting 1.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$106,000
-62.7%
164,607
+51.2%
0.00%
Q1 2022$284,000
-16.7%
108,838
+24.0%
0.00%
Q4 2021$341,000
-75.3%
87,786
-69.0%
0.00%
-100.0%
Q2 2020$1,378,000
+193.8%
283,418
+32.3%
0.00%
+100.0%
Q1 2020$469,000
-69.4%
214,222
-18.7%
0.00%
-50.0%
Q4 2019$1,533,000263,4170.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 11,503,294$55,848,00077.67%
Bracebridge Capital, LLC 428,571$2,083,0000.33%
Oak Grove Capital LLC 89,000$432,0000.20%
Perceptive Advisors 1,750,000$8,496,0000.12%
Virtu Financial LLC 117,206$569,0000.10%
WEDBUSH SECURITIES INC 103,240$501,0000.05%
J. Goldman & Co LP 117,600$571,0000.04%
Engineers Gate Manager LP 68,300$332,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 118,900$577,0000.01%
Brandywine Global Investment Management, LLC 137,029$666,0000.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders